Figure 4. pCMV-sHAPQ does not protect against lethal ASFV challenge.
(A) Surviving kinetics of pCMV, pCMV-pCMV-PQ and pCMV-sHAPQ immunized pigs after lethal challenge with ASFV (104 UHA of the E75 isolate). (B) Viremia kinetics of these same individuals after ASFV challenge (days 3, 5 and 7 post infection). Results are represented as the logarithm of HAU50/ml serum (mean and standard deviation from each group are shown).